Songbing Qin, MD, a visiting scientist to The Cancer Institute of New Jersey, has received the International - U.S. Annual Meeting Scientific Abstract Award at the 54th Annual Meeting of the American Society for Radiation Oncology (ASTRO) being held in Boston this week. The Cancer Institute of New Jersey is a Center of Excellence of the University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School (RWJMS).
The International - U.S. Annual Meeting Scientific Abstract Award was created to recognize outstanding abstracts submitted by clinicians early on in their career. Dr. Qin was selected for his submission "Motion Pattern for Liver Tumor and its Correlation to External Surrogates." Qin was the only investigator to receive the award in the international category.
Stereotactic Body Radiotherapy (SBRT) is a type of therapy in which large doses of radiation are delivered in fewer than five treatments. SBRT has been used to treat liver tumors that often exhibit significant movement while a treatment is being administered. The efficacy of SBRT on liver tumors may hinge on fully understanding tumor motion patterns and successful motion management since motion may complicate the treatment process or even compromise treatment outcomes.
Qin and colleagues investigated the motion pattern and magnitude of liver tumors and the correlation with external surrogates. Their research concluded that direct internal monitoring of liver tumors may be required for improved motion management.
Ning J. Yue, PhD, FAAPM, who leads the radiation physics team at The Cancer Institute of New Jersey and is the vice chair and chief of physics at RWJMS, collaborated on the work with Qin. "It is vital to recognize young scientists in this way, as they are the future of radiation oncology investigation. Dr. Qin's research represents the foundation of advances to come in our field, and it is exciting to see he is receiving international recognition for his efforts."
Expanding research and clinical options for children with cancer